|
Date |
Time |
Place |
Session / Title |
Role |
April 22 |
7:00 AM - 8:30 AM |
Cath Lab, Asan Medical Center, Level 3 |
Live Cases Review with Operators |
Case Reviewer |
April 22 |
10:50 AM - 12:10 PM |
CTO Theater, Level 1 |
CTO Live Case Session I |
Discussant |
April 22 |
1:10 PM - 2:30 PM |
Asan Medical Center, Level 3 |
CTO Live Case Session II Asan Medical Center, Seoul, Korea: Case #03 |
Operator 2nd |
April 22 |
2:00 PM - 2:55 PM |
Poster Abstract Zone, Level 3 |
Session I [TCTAP A-133] Impact of Percutaneous Coronary Intervention on 12-month Chronic Total Occlusion Outcomes in Patients with Myocardial Infarction |
Poster Abstract Presenter |
April 22 |
2:00 PM - 2:55 PM |
Poster Abstract Zone, Level 3 |
Session III [TCTAP A-160] Impact of Percutaneous Coronary Intervention for Chronic Total Occlusion in Elder Patients |
Poster Abstract Presenter |
April 22 |
2:00 PM - 2:55 PM |
Poster Abstract Zone, Level 3 |
Session III [TCTAP A-162] Impact of Percutaneous Coronary Intervention for Chronic Total Occlusion in Patients who Received Non-chronic Total Occlusion Lesion Intervention |
Poster Abstract Presenter |
April 22 |
2:00 PM - 2:55 PM |
Poster Abstract Zone, Level 3 |
Session III [TCTAP A-159] Impact of Percutaneous Coronary Intervention for Chronic Total Occlusion in Stroke Patients |
Poster Abstract Presenter |
April 22 |
2:00 PM - 2:55 PM |
Poster Abstract Zone, Level 3 |
Session III [TCTAP A-163] Impact of Percutaneous Coronary Intervention on 12-month Chronic Total Occlusion Outcomes in Patients with Limited Coronary Collateral Flow |
Poster Abstract Presenter |
April 22 |
2:00 PM - 2:55 PM |
Poster Abstract Zone, Level 3 |
Session III [TCTAP A-161] Impact of Percutaneous Coronary Intervention on 12-month Chronic Total Occlusion Outcomes in Patients with Non-lad Disease. |
Poster Abstract Presenter |
April 22 |
2:00 PM - 2:55 PM |
Poster Abstract Zone, Level 3 |
Session IV [TCTAP A-208] Twelve-month Angiographic and Clinical Outcomes Following Infrapopliteal Artery Intervention in Patients with Critical Limb Ischemia |
Poster Abstract Presenter |
April 22 |
2:00 PM - 2:55 PM |
Poster Abstract Zone, Level 3 |
Session IV [TCTAP A-201] Impact of Simvastatin on Development of New-onset Diabetes Mellitus in Asian Population: Three-year Clinical Follow up Results |
Poster Abstract Presenter |
April 22 |
2:00 PM - 2:55 PM |
Poster Abstract Zone, Level 3 |
Session V [TCTAP A-180] Impact of Drug-eluting Stent-associated Coronary Artery Spasm on 3-year Clinical Outcomes: A Propensity Score Matching Analysis |
Poster Abstract Presenter |
April 22 |
2:00 PM - 2:55 PM |
Poster Abstract Zone, Level 3 |
Session V [TCTAP A-179] Impact of Percutaneous Coronary Intervention for Left Anterior Descending Artery Chronic Total Occlusion |
Poster Abstract Presenter |
April 22 |
2:00 PM - 2:55 PM |
Poster Abstract Zone, Level 3 |
Session V [TCTAP A-175] Impact of Percutaneous Coronary Intervention on Twelve-month Chronic Total Occlusion Outcomes in Patients with Smoking History |
Poster Abstract Presenter |
April 22 |
2:00 PM - 2:55 PM |
Poster Abstract Zone, Level 3 |
Session V [TCTAP A-181] Predictors of Recurrent Chest Pain in Vasospastic Angina Patients from 3-year Clinical Outcome Data |
Poster Abstract Presenter |
April 22 |
2:00 PM - 2:55 PM |
Poster Abstract Zone, Level 3 |
Session V [TCTAP A-164] Impact of Percutaneous Coronary Intervention on 12-month Chronic Total Occlusion Outcomes in Patients with New Onset Heart Failure |
Poster Abstract Presenter |
April 23 |
11:30 AM - 12:30 PM |
Endovascular & Structural Heart Theater, Level 1 |
DEB: Treat with All Possibility and Preserve Future Option |
Panelist |
April 23 |
11:45 AM - 11:52 AM |
Endovascular & Structural Heart Theater, Level 1 |
DEB: Treat with All Possibility and Preserve Future Option DEB in In-stent Restenosis |
Lecturer |
April 23 |
12:45 PM - 1:45 PM |
Room 1-1, Level 1 |
How Can We Improve Personalized Medicine? A Close Look at Diabetics and Primary PCI? |
Panelist |
April 23 |
2:00 PM - 2:30 PM |
Room 1-2, Level 1 |
CCT Session @TCTAP 2014: Improve Success of CTO PCI |
Commentator |
April 23 |
3:40 PM - 3:50 PM |
Abstract Zone I, Level 3 |
1-2. Complex PCI I [TCTAP A-121] Transradial Versus Transfemoral Intervention in ST-segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention with Drug-eluting Stents |
Abstract Presenter |
April 23 |
5:00 PM - 6:00 PM |
Endovascular & Structural Heart Theater, Level 1 |
Live Case Session III. Below the Knee Intervention |
Discussant |
April 24 |
12:45 PM - 1:45 PM |
Room 4-1, Level 4 |
Otsuka Pletaal Luncheon Symposium |
Moderator |
April 24 |
2:00 PM - 2:10 PM |
Abstract Zone I, Level 3 |
1-9. Endovascular Intervention I [TCTAP A-097] Prevalence of Coronary Artery Disease in Critical Limb Ischemia Patients Undergoing Endovascular Therapy in Asian Population |
Abstract Presenter |
April 24 |
3:20 PM - 3:30 PM |
Abstract Zone I, Level 3 |
1-10. Endovascular Intervention II [TCTAP A-103] Impact of Pulse Pressure on 12-month Angiographic and Clinical Outcomes Following Endovascular Intervention in Patients with Critical Limb Ischemia |
Abstract Presenter |
April 24 |
4:20 PM - 4:30 PM |
Case Zone II, Level 3 |
2-11. Endovascular Intervention II [TCTAP C-192] A Successful Endovascular Stent Graft Treatment Case in Common Femoral Artery Rupture Induced During Femoral Catheterization |
Case Presenter |
April 24 |
5:40 PM - 5:50 PM |
Abstract Zone I, Level 3 |
1-12. Endovascular Intervention IV [TCTAP A-112] Comparison of 12-month Clinical Outcomes of Infrapopliteal Balloon Angioplasty Alone Versus Balloon Angioplasty with Provisional Stenting in Patients with Critical Limb Ischemia |
Abstract Presenter |
April 25 |
11:14 AM - 12:26 PM |
Room 1-2, Level 1 |
II-3. Endovascular Intervention II |
Moderator |